(Q44573142)

English

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. (English)

1 reference

Europe PubMed Central

4 December 2017

Alzheimer's disease

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

vascular dementia

1 reference

based on heuristic

inferred from title

dementia with Lewy bodies

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

4 December 2017

author name string

M Piggott

2

1 reference

Europe PubMed Central

4 December 2017

J Owens

3

1 reference

Europe PubMed Central

4 December 2017

E Greally

4

1 reference

Europe PubMed Central

4 December 2017

J A Court

5

1 reference

Europe PubMed Central

4 December 2017

E Jaros

6

1 reference

Europe PubMed Central

4 December 2017

R H Perry

7

1 reference

Europe PubMed Central

4 December 2017

E K Perry

8

1 reference

Europe PubMed Central

4 December 2017

D Wyper

9

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

4 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

4 December 2017

29

1 reference

Europe PubMed Central

4 December 2017

1

1 reference

Europe PubMed Central

4 December 2017

108-116

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300302

0 references

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic receptor abnormalities in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic receptors in human brain: topography and pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Targeting the subthalamic nucleus in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Neuronal nicotinic acetylcholine receptors as targets for drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic receptor abnormalities in the cerebellar cortex in autism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Neuronal nicotinic receptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

5-[I-125/123]lodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Cholinergic modulation, visual function and Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Neuronal nicotinic receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I] alpha-bungarotoxin binding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

21 January 2018

Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the cholinergic system in the development of the human cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autobiographic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of four classes of brain nicotinic receptors using beta2 mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300302

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300302

1 reference

Europe PubMed Central

4 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44573142&oldid=2110153085"